SALT LAKE CITY – Intermountain Healthcare has formed its own non-profit to manufacture and market generic drugs in order to combat increasing drug prices and shortages.
The new company, Civica Rx, won’t report to shareholders because it doesn’t have any.
“There’s nobody that has equity in the company,” said new CEO Martin VanTrieste, retired from drug maker Amgen.
“Any profit that we make we will put back into the business and we keep the prices as low as possible.”
VanTrieste says the company will go after pharmaceutical patents that have already paid off for their originators.
He also accuses them of creating shortages for their profits.
“We have over 200 shortage drugs that we’re managing at Intermountain Healthcare every day,” said hospital Vice President Dan Liljenquist.
“These are essential medications. When we don’t have them, patients are injured,” said Liljenquist.
Civica will start with 14 generic drugs most vital to hospitals but won’t say which to protect its competitive advantage.
Today’s Top Stories
- Officer Tanya Turnbow, Tooele City Police Department
- Train derailment causes mess near Milford
- 47-year-old mother of four graduates top of her class at UVU College of Science
- The 90 minutes that cost Principal Ford White his job
- What is an accessory dwelling unit? How ADU’s can help your finances, future, and your…
- Will Pettit – Granite Park Junior High
- Much loved St. George runner dies after 10-year fight with cancer
- Gov. Herbert announces COVID-19 to close schools rest of year
- Mrs. Jill Muhlestein – Elk Meadows Elementary
- Sifting through evidence in Lueck case will “take some time” according to police